碳水化合物限制对2型糖尿病的有益效应可追溯至肝脏代谢的改变
该研究纳入57例轻度2型糖尿病成人,比较12周等热量生酮饮食(约9%能量来自碳水、65%来自脂肪)与等热量低脂饮食(约55%能量来自碳水、20%来自脂肪)对肝脏代谢和β细胞功能的影响。生酮饮食组丙酮酸和棕榈油酸(DNL标志物)下降,空腹胰高血糖素升高、肝脏脂肪降低;肝脏脂肪变化与丙酮酸变化正相关,与胰高血糖素变化、胰高血糖素与C肽比值变化及急性C肽反应变化负相关。作者认为肝脏代谢转向促进脂肪氧化而非DNL可能是碳水化合物限制改善肝脂肪变性和葡萄糖诱导胰岛素分泌的机制。
要点
- 生酮饮食12周使丙酮酸降低23%(P<.001)、棕榈油酸降低32%(P<.01)。
- 生酮饮食组第12周空腹胰高血糖素较LFD组高25%(P<.05),肝脏脂肪低28%(P<.05)。
- 肝脏脂肪变化与丙酮酸变化正相关(r=0.45,P=.05),与胰高血糖素变化负相关(r=-0.34,P<.05)。
核心结论
- 肝脏代谢转向促进脂肪氧化而非DNL可能解释碳水化合物限制对肝脂肪变性和葡萄糖诱导胰岛素分泌的有益效应。
研究设计与样本
- 研究纳入57例轻度2型糖尿病成人,在基线和12周等热量生酮饮食(约9%能量来自碳水、65%来自脂肪)或等热量低脂饮食(约55%能量来自碳水、20%能量来自脂肪)后,用高血糖钳夹评估急性C肽反应、用磁共振成像评估肝脏脂肪分数。
主要发现
- 生酮饮食导致丙酮酸降低23%(P<.001)和棕榈油酸(DNL标志物)降低32%(P<.01)。
- 第12周时生酮饮食组空腹胰高血糖素较LFD组高25%(P<.05),肝脏脂肪较LFD组低28%(P<.05)。
- 全部参与者中,肝脏脂肪变化与丙酮酸变化正相关(r=0.45,P=.05),与胰高血糖素变化负相关(r=-0.34,P<.05),与胰高血糖素与C肽比值变化负相关(r=-0.44,P<.01),与急性C肽反应变化负相关(r=-0.34,P<.05)。
- 生酮饮食组急性C肽反应变化与丙酮酸变化负相关(r=-0.5,P<.05),LFD组无此关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Carbohydrate restriction benefits metabolic health in patients with type 2 diabetes (T2D), possibly through changes in hepatic metabolism. OBJECTIVE: To test the hypothesis that the ketogenic diet (KD) would decrease de novo lipogenesis (DNL) and liver fat, which would be associated with restored beta-cell function. METHODS: Participants were 57 adults with mild T2D. A hyperglycemic clamp was used to assess acute C-peptide response (ACP), and magnetic resonance imaging to assess hepatic fat fraction, at baseline and after 12 weeks of either a eucaloric KD (∼9% energy from carbohydrate, 65% energy from fat) or a eucaloric low-fat diet (LFD) (∼55% energy from carbohydrate, 20% energy from fat). RESULTS: The KD led to decreases in pyruvate (-23%, P < .001) and palmitoleic acid, a marker of DNL (-32%, P < .01). Participants on the KD had higher fasting glucagon (25%, P < .05) and lower liver fat (28%, P < .05) at week 12 than those on the LFD. In all combined, the change in liver fat was positively associated with the change in pyruvate (r = 0.45, P = .05), and inversely associated with changes in glucagon (r = -0.34, P < .05), the glucagon to C-peptide ratio (r = -0.44, P < .01), and ACP (r = -0.34, P < .05). The change in ACP was inversely associated with the change in pyruvate in the KD group (r = -0.5, P < .05), but not in the LFD group. CONCLUSION: A shift in hepatic metabolism to favor fat oxidation over DNL may underlie the beneficial effects of carbohydrate restriction on hepatic steatosis and glucose-induced insulin secretion.
引用
- Gower BA, Yurchishin ML, Goss AM, et al. Beneficial Effects of Carbohydrate Restriction in Type 2 Diabetes Can Be Traced to Changes in Hepatic Metabolism. J Clin Endocrinol Metab. 2025. PMID: 40448689. doi:10.1210/clinem/dgaf324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。